Labiotech.eu

News and Trends 22 Sep 2015

UniQure’s cure for rare Lysosomal disease ready for phase III trial

UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial targeting a rare Lysosomal disease. This has granted fast-track approval to launch its phase III trial for children with Sanfilippo Type B (MPS-III) in collaboration with France’s Institut Pasteur. UniQure is the Amsterdam gene-therapy biotech with a lot going on. Last year […]

September 22, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 22 Sep 2015

Selvita moves in: The biggest Polish biotech on the Boston Block

Welcome to the US! Polish Selvita has announced its new US HQ in Cambridge (MA), which they hope will better integrate their drug-discovery work into the US market. Selvita, from Krakow (Poland) is the largest Polish biotech with 265+ employees, 86 of which hold PhDs. Having been built on offering pre-clinical services to over 50 US/EU […]

September 22, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 21 Sep 2015

Shire’s Adderall alternative granted EMA approval for EU

Intuniv, Shire‘s new anti-stimulatory product for children with attention-deficit hyperactivity disorder (ADHD) between 6-17 years old, is set to hit shelves in Europe following successful market approval by the European medicine agency (EMA). Shire, a pharma giant with a €23.5Bn market cap, dominates the ADHD market. Originally from Basingstoke (England), they also have bases in the […]

September 21, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 21 Sep 2015

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

New GMO rice variety has an increased starch content coupled with low greenhouse gas emissions. By making these GM rices more eco-friendly as well as improving their nutritional value, this research could potentially sway the public and political stigma against this life-altering technology, in the mission to save millions. As we all know, grains such as Golden […]

September 21, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 19 Sep 2015

Swiss Biotech Boom: Life sciences startups dominate top 100 awards

Exciting news for the Swiss biotech frontline! The TOP 100 Start-Up award is hosted by Startup.ch the Swiss start-up platform (through IFJ Institut für Jungunternehmen) in collaboration with the major paper Handelszeitung and PME Magazine, ranking the 100 most promising new start up companies. Of these 100, a whopping 68 of these start-ups are in the […]

September 19, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Sep 2015

Discover the Worlds first Bioactive Toilet Paper from Italy

Papernet biotech (part of the Italian Sofidel Group) launched their biological toilet paper back in 2007 as an answer to our hygiene based ecological crisis. With over 7Bn rolls produced per year in the US alone, Papernet is an award-winning subsidiary of the hygiene giant’s portfolio. The invention of using paper for hygiene purposes was […]

September 18, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 18 Sep 2015

Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III

Treatment of diabetes hasn’t changed so much since the development of first human insulin by Genentech. But Boston-based Intarcia (a partner of Servier and one of the 9 billion-dollar Biotech startups worldwide) has just published positive phase III results of its implantable device aiming at changing how type 2 diabetes are treated. November 2014: I thought […]

September 18, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 17 Sep 2015

France’s leading Female Bio-entrepreneur joins board of Abivax

Dominique Costantini is one of France’s leading biotech figures, with over 20 years experience on boards, partnerships and business backing in some of the biotech industries leading brands. With a medical background specializing in immunology (from Paris V University), Costantini co-founded oncology focused Onxeo in 1997. Formerly known as BioAlliance Pharma, this biotech went public […]

September 17, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 17 Sep 2015

Forbion’s Dutch biotech draws Cali’s Amgen into €1.36Bn deal

Californian Amgen has announced its plans to acquire the Dutch pharma Dezima off of Forbion for €265M upfront. An additional €1.1Bn will be paid through development on their cardiovascular drug candidate which has shown good results in its phase II trial. Amgen is set to buy out Forbion’s portfolio of Amsterdam based Dezima Pharma, a […]

September 17, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 17 Sep 2015

This new Bioplastic plant integrates breakthrough Biotech innovations

Bioplastics hasn’t replaced plastics yet. One new milestone has now been reached, the French company Carbios has just opened its pilot plant to produce biodegradable plastics thanks to its breakthrough enzyme-based technology. Whilst various green initiatives push for better regulation of recycling (a prime example being in Berlin!), in reality only around 10% of plastic […]

September 17, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 17 Sep 2015

Welcome to the Golden age for Gene Editing!

Nuclease-based gene editing technology has opened up how biotechs approach genomic research in industry. A review by Boston Consulting Group explores the background to this excitingly complex field, highlighting how the lengthy genetic revolution has been leading up to this point. Boston Consulting Group has released a report on the importance of gene editing to […]

September 17, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 16 Sep 2015

Desktop Genetics bags €1.87M from top UK business angels to change how you manage your CRIPSR experiments

Gene Editing has been made much easier thanks to CRISPR but managing your genome editing workflow can be a challenge. London-based Desktop Genetics wants to solve this problem and just raised additional funding to accelerate its development. CRISPR is already considered as the biotech revolution of this century. Having an easy tool is one thing, but being […]

September 16, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

UniQure’s cure for rare Lysosomal disease ready for phase III trial

Selvita moves in: The biggest Polish biotech on the Boston Block

Shire’s Adderall alternative granted EMA approval for EU

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

Swiss Biotech Boom: Life sciences startups dominate top 100 awards

Discover the Worlds first Bioactive Toilet Paper from Italy

Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III

France’s leading Female Bio-entrepreneur joins board of Abivax

Forbion’s Dutch biotech draws Cali’s Amgen into €1.36Bn deal

This new Bioplastic plant integrates breakthrough Biotech innovations

Welcome to the Golden age for Gene Editing!

Desktop Genetics bags €1.87M from top UK business angels to change how you manage your CRIPSR experiments

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!